Upper Respiratory Infection Clinical Trial
NCT number | NCT01916031 |
Other study ID # | AAAD7081 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | August 1, 2013 |
Last updated | August 1, 2013 |
Est. completion date | May 2010 |
Verified date | August 2013 |
Source | Columbia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to comparatively assess the effectiveness of a tailored educational intervention to improve health literacy levels regarding upper respiratory infections (URIs) and to decrease pediatric emergency department (PED) visits, among Latino households in Early Head Start.
Status | Completed |
Enrollment | 0 |
Est. completion date | May 2010 |
Est. primary completion date | May 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Attending an infant or toddler EHS group at participating site Exclusion Criteria: - Participant in pilot study - Participant in community intervention regarding URI |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Columbia University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of pediatric emergency department visits | 5 months | No | |
Secondary | Use of over-the-counter medication | 5 months | No | |
Secondary | Use of incorrect measuring tool | 5 months | No | |
Secondary | Use of unprescribed antibiotic | 5 months | No | |
Secondary | Knowledge regarding URI | Composite score | 5 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03711292 -
Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings
|
N/A | |
Completed |
NCT01168778 -
Improving Communication During Pediatric Visits for Acute Respiratory Illness
|
N/A | |
Terminated |
NCT00187785 -
Doctor-Patient Communication in Spanish
|
N/A | |
Completed |
NCT00405509 -
The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years
|
N/A | |
Completed |
NCT00189475 -
Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds
|
Phase 4 | |
Completed |
NCT04468204 -
Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI)
|
N/A | |
Active, not recruiting |
NCT05666752 -
Effect of Intake of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement
|
N/A | |
Completed |
NCT00255307 -
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
|
Phase 2 | |
Suspended |
NCT05035420 -
A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases
|
N/A | |
Recruiting |
NCT06244615 -
Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat
|
N/A | |
Completed |
NCT02694679 -
Randomized Controlled Trial of Social Network Targeting in Honduras
|
N/A | |
Completed |
NCT05352581 -
BD Veritorâ„¢ At-Home and BD Veritorâ„¢ Professional
|
||
Active, not recruiting |
NCT02943551 -
Dialogue Around Respiratory Illness Treatment
|
N/A | |
Completed |
NCT01657643 -
Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections
|
N/A | |
Completed |
NCT02110732 -
Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil
|
N/A | |
Completed |
NCT00694421 -
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
|
N/A | |
Completed |
NCT03884777 -
Incidence and Risk of Influenza in Myasthenic Patients
|
||
Completed |
NCT00796315 -
Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children
|
Phase 1 | |
Completed |
NCT00642681 -
Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge
|
Phase 2 | |
Completed |
NCT00259831 -
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
|
Phase 3 |